Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Allurion Technologies ( (ALUR) ) has shared an announcement.
At its annual meeting on December 18, 2025, Allurion Technologies, Inc. re-elected directors Omar Ishrak, Douglas Hudson and R. Jason Richey to serve until the 2028 annual meeting and ratified Deloitte & Touche LLP as its independent auditor for the 2025 fiscal year. Shareholders also approved an amended and restated 2023 Stock Option and Incentive Plan that increases the share pool, extends the plan term, revises the fully diluted share definition and lowers non-employee director compensation limits, as well as the repricing of certain existing stock options. In addition, investors authorized the issuance of common shares upon conversion of Series B preferred stock and the exercise of private placement warrants to ensure compliance with New York Stock Exchange listing rules, and backed a share consolidation authorization allowing the board to implement a reverse stock split in a range of 1-for-1.5 to 1-for-20, steps that collectively enhance the company’s capital structure flexibility and support its continued listing and governance framework.
The most recent analyst rating on (ALUR) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on Allurion Technologies stock, see the ALUR Stock Forecast page.
Spark’s Take on ALUR Stock
According to Spark, TipRanks’ AI Analyst, ALUR is a Neutral.
Allurion Technologies’ overall stock score is primarily impacted by its poor financial performance, characterized by declining revenue, persistent losses, and high leverage. While the earnings call provided some positive long-term strategic initiatives, the immediate financial challenges and bearish technical indicators weigh heavily on the stock’s attractiveness.
To see Spark’s full report on ALUR stock, click here.
More about Allurion Technologies
Allurion Technologies, Inc. operates in the healthcare and medical technology sector, focusing on weight-loss and metabolic health solutions. The company’s offerings are aimed at patients and providers seeking less invasive alternatives to traditional bariatric procedures, with a business model that relies on continued innovation and alignment with public-market listing requirements.
Average Trading Volume: 194,145
Technical Sentiment Signal: Sell
Current Market Cap: $13.89M
Learn more about ALUR stock on TipRanks’ Stock Analysis page.